Answer
Sep 01, 2026 - 11:30 AM
This medication is generally considered after anti-EGFR agents are no longer effective. Anti-EGFR agents block signals that help cancer cells grow; having additional options after resistance is valuable in cancer care.
Is this compatible with anti-EGFR agents? Lonsurf Medications
Status:
Open Sep 01, 2026 - 11:30 AM
Do you have the same question? Follow this Question
1answer
Browse by Category
Medications
View our complete selection of Medications to find the one that suites your needs.
View All
View all Medications Questions & Answers
View all Lonsurf Questions & Answers
